Symbols / NRXS Stock $7.86 +5.50% NeurAxis, Inc.

Healthcare • Biotechnology • United States • ASE
NRXS (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Mr. Brian Carrico
Exch · Country ASE · United States
Market Cap 90.43M
Enterprise Value 83.40M
Income -8.62M
Sales 3.57M
FCF (ttm) -3.86M
Book/sh 0.32
Cash/sh 0.44
Employees 24
Insider 10d —
IPO Aug 09, 2023
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -262.00
PEG —
P/S 25.34
P/B 24.64
P/C —
EV/EBITDA -11.68
EV/Sales 23.37
Quick Ratio 1.85
Current Ratio 2.05
Debt/Eq 12.55
LT Debt/Eq —
EPS (ttm) -0.95
EPS next Y -0.03
EPS Growth —
Revenue Growth 27.20%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-03-19
Earnings (prior) 2026-03-19
ROA -80.63%
ROE -285.36%
ROIC —
Gross Margin 84.23%
Oper. Margin -177.34%
Profit Margin -218.55%
Shs Outstand 11.51M
Shs Float 7.52M
Insider Own 22.96%
Instit Own 22.17%
Short Float 3.08%
Short Ratio 1.29
Short Interest 263.60K
52W High 8.40
vs 52W High -6.43%
52W Low 1.94
vs 52W Low 304.74%
Beta 1.89
Impl. Vol. —
Rel Volume 3.26
Avg Volume 162.46K
Volume 529.21K
Target (mean) $11.00
Tgt Median $11.00
Tgt Low $9.00
Tgt High $13.00
# Analysts 2
Recom Strong_buy
Prev Close $7.45
Price $7.86
Change 5.50%
About

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8 years of age with functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD) and associated FD nausea symptoms. The company also offers rectal expulsion device, a screening tool that helps to detects evacuation disorders. It sells its products to healthcare companies, such as hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. NeurAxis, Inc. was founded in 2011 and is headquartered in Carmel, Indiana.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$11.00
Mean price target
2. Current target
$7.86
Latest analyst target
3. DCF / Fair value
$-6.04
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$7.86
Low
$9.00
High
$13.00
Mean
$11.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-20 main Craig-Hallum Buy → Buy $13
2025-12-22 main Craig-Hallum Buy → Buy $8
2025-06-16 init Craig-Hallum — → Buy $7
News
RSS: Latest NRXS news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-01 CARRICO THOMAS JOESEPH Officer — 667 $7.18 $4,789
2026-04-01 CARRICO BRIAN ALLEN Chief Executive Officer — 8,060 $7.18 $57,871
2026-04-01 HENRICHS TIMOTHY ROBERT Chief Financial Officer — 7,593 $7.18 $54,518
2026-02-12 HANNASCH BRIAN Beneficial Owner of more than 10% of a Class of Security — 80,000 $4.65 $382,800
2026-01-22 FERGE KRISTIN A Director — 21,598 $4.63 $99,999
2026-01-22 AHARON GILAD S. Director — 21,598 $4.63 $99,999
2026-01-22 WATKINS BRADLEY MITCHELL Director — 21,598 $4.63 $99,999
2026-01-22 KEYSER JANE ELIZABETH Director — 21,598 $4.63 $99,999
2025-12-23 AHARON GILAD S. Director — 286,138 $3.52 $1,007,206
2025-07-01 HANNASCH BRIAN Beneficial Owner of more than 10% of a Class of Security — 355,556 $2.25 $800,001
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
3.57
+32.89%
2.69
+9.18%
2.46
-8.37%
2.68
Operating Revenue
3.57
+32.89%
2.69
+9.18%
2.46
-8.37%
2.68
Cost Of Revenue
0.56
+55.50%
0.36
+19.34%
0.30
+2.12%
0.30
Reconciled Cost Of Revenue
0.56
+55.50%
0.36
+19.34%
0.30
+2.12%
0.30
Gross Profit
3.01
+29.37%
2.32
+7.75%
2.16
-9.67%
2.39
Operating Expense
10.84
+14.30%
9.48
+7.48%
8.82
+53.15%
5.76
Research And Development
0.49
+13.84%
0.43
+156.10%
0.17
-24.95%
0.23
Selling General And Administration
10.34
+14.32%
9.05
+4.57%
8.65
+56.33%
5.53
Selling And Marketing Expense
2.28
+55.22%
1.47
+353.96%
0.32
-21.25%
0.41
General And Administrative Expense
8.06
+6.39%
7.58
-9.01%
8.33
+62.55%
5.12
Other Gand A
8.06
+6.39%
7.58
-9.01%
8.33
+62.55%
5.12
Total Expenses
11.40
+15.81%
9.84
+7.87%
9.12
+50.65%
6.06
Operating Income
-7.83
-9.40%
-7.16
-7.39%
-6.66
-97.63%
-3.37
Total Operating Income As Reported
-7.83
-9.40%
-7.16
-7.39%
-6.66
-97.63%
-3.37
EBITDA
-7.67
+2.98%
-7.90
+14.36%
-9.23
-113.35%
-4.33
Normalized EBITDA
-7.66
+3.07%
-7.90
-19.33%
-6.62
-17.30%
-5.65
Reconciled Depreciation
0.06
+57.28%
0.04
-7.11%
0.04
+9.67%
0.04
EBIT
-7.73
+2.70%
-7.94
+14.33%
-9.27
-112.46%
-4.36
Total Unusual Items
-0.01
-711.26%
-0.00
+99.96%
-2.61
-297.43%
1.32
Total Unusual Items Excluding Goodwill
-0.01
-711.26%
-0.00
+99.96%
-2.61
-297.43%
1.32
Special Income Charges
0.00
0.00
+100.00%
-3.65
0.00
Other Special Charges
—
—
3.65
—
Net Income
-7.80
+5.35%
-8.24
+43.65%
-14.63
-205.99%
-4.78
Pretax Income
-7.80
+5.35%
-8.24
+43.65%
-14.63
-205.99%
-4.78
Net Non Operating Interest Income Expense
-0.10
+80.39%
-0.53
+90.08%
-5.36
-95.66%
-2.74
Interest Expense Non Operating
0.07
-75.40%
0.30
-94.39%
5.36
+1183.05%
0.42
Net Interest Income
-0.10
+80.39%
-0.53
+90.08%
-5.36
-95.66%
-2.74
Interest Expense
0.07
-75.40%
0.30
-94.39%
5.36
+1183.05%
0.42
Interest Income Non Operating
—
—
—
—
Interest Income
—
—
—
—
Other Income Expense
0.13
+124.15%
-0.55
+78.74%
-2.60
-295.30%
1.33
Other Non Operating Income Expenses
0.14
+125.57%
-0.55
-11657.22%
0.00
-60.04%
0.01
Gain On Sale Of Security
-0.01
-711.26%
-0.00
-100.09%
1.04
-20.96%
1.32
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-7.80
+5.35%
-8.24
+43.65%
-14.63
-205.99%
-4.78
Net Income From Continuing Operation Net Minority Interest
-7.80
+5.35%
-8.24
+43.65%
-14.63
-205.99%
-4.78
Net Income From Continuing And Discontinued Operation
-7.80
+5.35%
-8.24
+43.65%
-14.63
-205.99%
-4.78
Net Income Continuous Operations
-7.80
+5.35%
-8.24
+43.65%
-14.63
-205.99%
-4.78
Normalized Income
-7.79
+5.43%
-8.24
+31.45%
-12.02
-97.05%
-6.10
Net Income Common Stockholders
-8.62
-1.92%
-8.45
+42.21%
-14.63
-163.78%
-5.54
Diluted EPS
—
-1.22
+45.71%
-2.25
-148.83%
-0.90
Basic EPS
—
-1.22
+45.71%
-2.25
-148.83%
-0.90
Basic Average Shares
—
6.92
+6.30%
6.51
+6.01%
6.14
Diluted Average Shares
—
6.92
+6.30%
6.51
-22.63%
8.41
Diluted NI Availto Com Stockholders
-8.62
-1.92%
-8.45
+42.21%
-14.63
-163.78%
-5.54
Preferred Stock Dividends
0.81
+285.58%
0.21
—
0.76
Total Other Finance Cost
0.03
-86.90%
0.23
+8226.98%
0.00
-99.88%
2.32
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
6.40
+34.61%
4.76
+833.78%
0.51
-65.59%
1.48
Current Assets
5.73
+34.39%
4.27
+1658.45%
0.24
-49.13%
0.48
Cash Cash Equivalents And Short Term Investments
4.97
+34.30%
3.70
+4605.79%
0.08
-69.03%
0.25
Cash And Cash Equivalents
4.97
+34.30%
3.70
+4605.79%
0.08
-69.03%
0.25
Cash Financial
4.97
+34.30%
3.70
+4605.79%
0.08
—
Receivables
0.20
-20.00%
0.24
+234.33%
0.07
-58.05%
0.17
Accounts Receivable
0.20
-20.00%
0.24
+234.33%
0.07
-58.05%
0.17
Gross Accounts Receivable
0.20
-18.66%
0.25
+193.12%
0.09
—
Allowance For Doubtful Accounts Receivable
-0.01
-46.52%
-0.01
+58.31%
-0.01
—
Inventory
0.26
+480.07%
0.04
+108.90%
0.02
-55.91%
0.05
Prepaid Assets
0.24
+8.34%
0.23
—
—
Other Current Assets
0.07
+29.52%
0.05
-21.76%
0.07
+9495.45%
0.00
Total Non Current Assets
0.67
+36.52%
0.49
+84.12%
0.27
-73.41%
1.00
Net PPE
0.34
-10.01%
0.37
+135.90%
0.16
-16.15%
0.19
Gross PPE
0.64
-14.02%
0.75
+47.78%
0.51
-0.07%
0.51
Accumulated Depreciation
-0.31
+18.03%
-0.37
-7.57%
-0.35
-9.51%
-0.32
Properties
0.00
0.00
0.00
0.00
Buildings And Improvements
0.26
-8.11%
0.28
+305.13%
0.07
-30.69%
0.10
Machinery Furniture Equipment
0.38
-13.73%
0.44
+6.68%
0.42
+8.00%
0.38
Other Properties
—
—
0.07
-30.69%
0.10
Leases
0.00
-100.00%
0.02
+0.00%
0.02
+0.00%
0.02
Goodwill And Other Intangible Assets
0.27
+184.48%
0.10
-10.63%
0.11
+39.34%
0.08
Other Intangible Assets
0.27
+184.48%
0.10
-10.63%
0.11
+39.34%
0.08
Non Current Deferred Assets
0.02
0.00
0.00
-100.00%
0.74
Non Current Prepaid Assets
0.04
+73.96%
0.02
0.00
—
Total Liabilities Net Minority Interest
3.00
+11.70%
2.69
+40.63%
1.91
-72.89%
7.05
Current Liabilities
2.79
+14.74%
2.43
+29.04%
1.89
-72.98%
6.98
Payables And Accrued Expenses
0.48
-47.46%
0.91
-28.18%
1.27
-32.59%
1.89
Payables
0.14
-76.65%
0.60
-50.43%
1.20
-24.36%
1.59
Accounts Payable
0.14
-76.65%
0.60
-50.43%
1.20
-24.36%
1.59
Current Accrued Expenses
0.34
+7.61%
0.32
+368.06%
0.07
-77.04%
0.29
Pensionand Other Post Retirement Benefit Plans Current
1.36
+7.82%
1.26
+278.23%
0.33
-38.19%
0.54
Total Tax Payable
—
—
—
0.00
Current Debt And Capital Lease Obligation
0.21
-1.32%
0.22
+10.00%
0.20
-62.27%
0.52
Current Debt
0.15
-3.80%
0.15
+4.11%
0.15
-69.74%
0.49
Other Current Borrowings
—
—
—
0.23
Current Capital Lease Obligation
0.07
+4.78%
0.06
+27.74%
0.05
+47.11%
0.03
Current Deferred Liabilities
0.03
-11.89%
0.03
-56.60%
0.07
+26.66%
0.06
Current Deferred Revenue
0.03
-11.89%
0.03
-56.60%
0.07
+26.66%
0.06
Other Current Liabilities
0.02
+83.29%
0.01
+11.44%
0.01
-99.79%
3.97
Total Non Current Liabilities Net Minority Interest
0.21
-17.13%
0.26
+847.50%
0.03
-64.47%
0.08
Long Term Debt And Capital Lease Obligation
0.20
-21.03%
0.26
+847.50%
0.03
-64.47%
0.08
Long Term Debt
—
—
—
—
Long Term Capital Lease Obligation
0.20
-21.03%
0.26
+847.50%
0.03
-64.47%
0.08
Other Non Current Liabilities
0.01
—
—
—
Stockholders Equity
3.40
+64.40%
2.07
+247.36%
-1.40
+74.82%
-5.57
Common Stock Equity
3.40
+64.56%
2.06
+247.05%
-1.40
+74.83%
-5.57
Capital Stock
0.01
+28.21%
0.01
+73.16%
0.01
+151.80%
0.00
Common Stock
0.01
+52.40%
0.01
+7.39%
0.01
+231.58%
0.00
Preferred Stock
0.00
-11.31%
0.00
0.00
-100.00%
0.00
Share Issued
10.65
+52.40%
6.99
+7.39%
6.51
+7.73%
6.04
Ordinary Shares Number
10.65
+52.40%
6.99
+7.39%
6.51
+7.73%
6.04
Additional Paid In Capital
67.99
+15.51%
58.86
+24.83%
47.15
+66.28%
28.36
Retained Earnings
-64.60
-13.73%
-56.80
-16.97%
-48.56
-43.11%
-33.93
Total Equity Gross Minority Interest
3.40
+64.40%
2.07
+247.36%
-1.40
+74.82%
-5.57
Total Capitalization
3.40
+64.40%
2.07
+247.36%
-1.40
+74.82%
-5.57
Working Capital
2.94
+60.46%
1.83
+211.55%
-1.64
+74.73%
-6.50
Invested Capital
3.54
+59.81%
2.22
+276.68%
-1.26
+75.32%
-5.09
Total Debt
0.42
-12.00%
0.47
+111.10%
0.22
-62.55%
0.60
Net Debt
—
—
0.07
-70.49%
0.24
Capital Lease Obligations
0.27
-15.95%
0.32
+318.98%
0.08
-30.47%
0.11
Net Tangible Assets
3.12
+58.52%
1.97
+230.43%
-1.51
+73.26%
-5.65
Tangible Book Value
3.12
+58.67%
1.97
+230.14%
-1.51
+73.26%
-5.65
Current Notes Payable
0.15
-3.80%
0.15
+4.11%
0.15
-43.25%
0.26
Current Provisions
0.69
—
—
—
Interest Payable
0.07
+0.00%
0.07
+0.00%
0.07
-67.56%
0.21
Inventories Adjustments Allowances
-0.03
-675.12%
-0.00
—
—
Other Inventories
0.29
+497.88%
0.05
—
—
Preferred Stock Equity
0.00
-11.31%
0.00
—
0.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-6.43
-5.49%
-6.10
+8.90%
-6.69
-191.30%
-2.30
Cash Flow From Continuing Operating Activities
-6.43
-5.49%
-6.10
+8.90%
-6.69
-191.30%
-2.30
Net Income From Continuing Operations
-7.80
+5.35%
-8.24
+43.65%
-14.63
-205.99%
-4.78
Depreciation Amortization Depletion
0.06
+57.28%
0.04
-7.11%
0.04
+9.67%
0.04
Depreciation And Amortization
0.06
+57.28%
0.04
-7.11%
0.04
+9.67%
0.04
Other Non Cash Items
0.05
-86.30%
0.39
-92.48%
5.18
+111.47%
2.45
Stock Based Compensation
0.60
-57.49%
1.40
+87.22%
0.75
+2645.34%
0.03
Provisionand Write Offof Assets
0.03
+173.41%
0.01
-53.13%
0.03
+29.61%
0.02
Operating Gains Losses
0.02
-90.22%
0.16
-93.91%
2.61
+297.43%
-1.32
Gain Loss On Investment Securities
0.01
-95.19%
0.16
+115.21%
-1.04
+20.96%
-1.32
Gain Loss On Sale Of PPE
0.01
0.00
—
—
Change In Working Capital
0.61
+331.49%
0.14
+121.24%
-0.67
-152.40%
1.27
Change In Receivables
0.05
+126.05%
-0.18
-335.47%
0.08
+196.63%
-0.08
Changes In Account Receivables
0.05
+126.05%
-0.18
-335.47%
0.08
+196.63%
-0.08
Change In Inventory
-0.24
-647.30%
-0.03
-220.76%
0.03
+400.60%
-0.01
Change In Prepaid Assets
0.24
+1626.05%
0.01
+125.84%
-0.05
-1211.98%
0.00
Change In Payables And Accrued Expense
0.63
+82.57%
0.34
+150.20%
-0.68
-149.40%
1.38
Change In Accrued Expense
1.08
+14.01%
0.95
+422.86%
-0.29
-207.98%
0.27
Change In Payable
-0.46
+24.65%
-0.61
-56.56%
-0.39
-135.00%
1.11
Change In Account Payable
-0.46
+24.65%
-0.61
-56.56%
-0.39
-135.00%
1.11
Change In Other Working Capital
—
—
0.02
+255.20%
-0.01
Change In Other Current Liabilities
-0.06
-1535.85%
-0.00
+89.78%
-0.03
-21.08%
-0.03
Investing Cash Flow
-0.13
-372.17%
-0.03
+61.30%
-0.07
-17.28%
-0.06
Cash Flow From Continuing Investing Activities
-0.13
-372.17%
-0.03
+61.30%
-0.07
-17.28%
-0.06
Net PPE Purchase And Sale
-0.03
-12.15%
-0.03
+9.76%
-0.03
-2114.46%
-0.00
Purchase Of PPE
-0.03
-12.15%
-0.03
+9.76%
-0.03
-2114.46%
-0.00
Capital Expenditure
-0.13
-372.17%
-0.03
+61.30%
-0.07
-17.28%
-0.06
Net Intangibles Purchase And Sale
-0.10
0.00
+100.00%
-0.04
+31.46%
-0.06
Purchase Of Intangibles
-0.10
0.00
+100.00%
-0.04
+31.46%
-0.06
Financing Cash Flow
7.83
-19.62%
9.74
+47.85%
6.59
+187.54%
2.29
Cash Flow From Continuing Financing Activities
7.83
-19.62%
9.74
+48.30%
6.57
+186.67%
2.29
Net Issuance Payments Of Debt
-0.28
-106.05%
4.66
+125.50%
2.07
-34.59%
3.16
Issuance Of Debt
0.00
-100.00%
4.94
-12.19%
5.62
+69.17%
3.32
Repayment Of Debt
-0.28
-2.09%
-0.28
+92.23%
-3.55
-2077.37%
-0.16
Long Term Debt Issuance
—
—
—
0.12
Long Term Debt Payments
—
—
—
-0.16
Net Long Term Debt Issuance
—
—
—
-0.04
Short Term Debt Issuance
0.00
-100.00%
4.94
-12.19%
5.62
+69.17%
3.32
Short Term Debt Payments
-0.28
-2.09%
-0.28
+92.23%
-3.55
-2077.37%
-0.16
Net Short Term Debt Issuance
-0.28
-106.05%
4.66
+125.50%
2.07
-34.59%
3.16
Net Common Stock Issuance
7.73
0.00
-100.00%
4.85
0.00
Proceeds From Stock Option Exercised
1.10
+4094.77%
0.03
-87.48%
0.21
0.00
Net Other Financing Charges
-0.71
-266.41%
-0.19
+63.44%
-0.53
+38.62%
-0.87
Changes In Cash
1.27
-64.95%
3.62
+2165.96%
-0.18
-160.78%
-0.07
Beginning Cash Position
3.70
+4605.79%
0.08
-69.03%
0.25
-20.93%
0.32
End Cash Position
4.97
+34.30%
3.70
+4605.79%
0.08
-69.03%
0.25
Free Cash Flow
-6.56
-7.15%
-6.13
+9.46%
-6.77
-186.78%
-2.36
Interest Paid Supplemental Data
0.01
-64.96%
0.03
-84.23%
0.21
+5.81%
0.20
Income Tax Paid Supplemental Data
0.01
+29.28%
0.01
0.00
0.00
Common Stock Issuance
7.73
0.00
-100.00%
4.85
0.00
Issuance Of Capital Stock
7.73
+47.11%
5.25
+8.38%
4.85
0.00
Net Preferred Stock Issuance
0.00
-100.00%
5.25
0.00
0.00
Preferred Stock Issuance
0.00
-100.00%
5.25
0.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category